SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tokyo VD who wrote (1943)1/22/1998 12:22:00 PM
From: khrnyc  Read Replies (2) of 7041
 
Good morning Tokyo,

The efficacy data I referred to regarding the Phase III Vasomax trials were presented at the Second Annual Symposium on the Pharmacologic Management of Male Sexual Dysfunction. The specific data that was not available at that conference pertained to half-life, blood concentrations, etc...

As for your second question, on a conference call last year for an investment bank I did discuss the market for protease inhibitors in the treatment of HIV/AIDS. I was not paid for doing so.

As for the previous post regarding my hours on the net, I am off hospital teaching duties this month and thought this might be a productive use of time. While I must admit, I didn't expect it to take up this much time, I do think it's so far been a good exercise.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext